Source: Critical Care. Conference titles: International Symposium on Intensive Care and Emergency Medicine for Latin America. Unidades: FM, FCF
Subjects: SEPSE, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KUPA, Leonard de Vinci Kanda et al. Meropenem extended infusion to guarantee drug effectiveness against nosocomial MIC 4 mg/l strains in burn patients at the earlier period of septic shock. Critical Care. London: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1186/s13054-019-2503-9. Acesso em: 15 maio 2024. , 2019APA
Kupa, L. de V. K., Silva Júnior, J. M. da, Silva Junior, E. M. da, Oliveira, A. M. R. R. de, Gomides, A. S., Silva, C. C. da, et al. (2019). Meropenem extended infusion to guarantee drug effectiveness against nosocomial MIC 4 mg/l strains in burn patients at the earlier period of septic shock. Critical Care. London: Faculdade de Medicina, Universidade de São Paulo. doi:10.1186/s13054-019-2503-9NLM
Kupa L de VK, Silva Júnior JM da, Silva Junior EM da, Oliveira AMRR de, Gomides AS, Silva CC da, Ferreira GA, Oliveira TC, Duarte NJC, Gomez D de S, Guillaux CS, Santos SRCJ. Meropenem extended infusion to guarantee drug effectiveness against nosocomial MIC 4 mg/l strains in burn patients at the earlier period of septic shock [Internet]. Critical Care. 2019 ; 23 17 res. P31.[citado 2024 maio 15 ] Available from: https://doi.org/10.1186/s13054-019-2503-9Vancouver
Kupa L de VK, Silva Júnior JM da, Silva Junior EM da, Oliveira AMRR de, Gomides AS, Silva CC da, Ferreira GA, Oliveira TC, Duarte NJC, Gomez D de S, Guillaux CS, Santos SRCJ. Meropenem extended infusion to guarantee drug effectiveness against nosocomial MIC 4 mg/l strains in burn patients at the earlier period of septic shock [Internet]. Critical Care. 2019 ; 23 17 res. P31.[citado 2024 maio 15 ] Available from: https://doi.org/10.1186/s13054-019-2503-9